Participating glioblastoma patients had a median survival of 24.1 months, and the authors observed a trend towards prolonged survival with exercise.
Journal of Neuro-Oncology · 9 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Participating glioblastoma patients had a median survival of 24.1 months, and the authors observed a trend towards prolonged survival with exercise.
This is a retrospective analysis of a single-center, supervised exercise program (ActiNO) for 45 glioma patients, including those with glioblastoma (58%) and lower-grade astrocytoma (29%). The program involved two individualized weekly sessions of bicycle ergometry and resistance training. Patients achieved at least 75% of age-adjusted maximum heart rate during fitness assessment. The median survival for participating glioblastoma patients was 24.1 months. The authors note a trend towards prolonged survival with exercise, which is hypothesis-generating. Limitations include the retrospective design, potential selection bias (participants were motivated and had above-average initial fitness), and the heterogeneity of tumor types. The findings suggest intensive submaximal exercise is tolerable and warrants prospective study to objectify benefits in physical performance and quality of life.